Interestingly, treatment with the nonsteroid anti‐inflammatory drug (NSAID) aspirin, which inhibits both COX‐1 and COX‐2, seems to reduce the risk of developing CRC [11, 12]. This evidence concerns the gene PTGS1 and colorectal carcinoma.